Patient characteristics
Parameter . | Subgroup of patients . | |
---|---|---|
Donor (n = 96) . | No donor (n = 161) . | |
Median age, y (range) | 31 (16-55) | 26 (15-54) |
Sex | ||
Male | 58 (60) | 96 (60) |
Female | 38 (40) | 65 (40) |
Immunophenotype (No.) | ||
Precursor B cell | 65 (68) | 121 (75) |
Precursor T cell | 28 (29) | 38 (24) |
Not specified | 3 | 2 |
WBC, × 109/L (No. [%]) | ||
≤ 30 | 64 (67) | 118 (73) |
30-100 | 18 (19) | 26 (16) |
> 100 | 14 (15) | 17 (11) |
Cytogenetics successful (No. [%]) | 79 (82) | 130 (81) |
Cytogenetic poor-risk features* | ||
t(9;22) | 17 (22) | 21 (16) |
t(4;11) | 4 (5) | 4 (3) |
t(1;19) | 1 (1) | 3 (2) |
Cycles to CR (No. [%]) | ||
1 | 87 (91) | 148 (92) |
2-3 | 9 (9) | 13 (8) |
Prognostic risk category (No. [%])† | ||
Standard | 50 (52) | 88 (55) |
Poor | 46 (48) | 73 (45) |
Time from diagnosis until SCT, mo | ||
Median (range) | 5.2 (2.8-10.8) | 5.4 (3.2-10.2) |
Time from CR1 until SCT, mo | ||
Median (range) | 3.8 (0.5-9.2) | 3.9 (0.4-8.9) |
Parameter . | Subgroup of patients . | |
---|---|---|
Donor (n = 96) . | No donor (n = 161) . | |
Median age, y (range) | 31 (16-55) | 26 (15-54) |
Sex | ||
Male | 58 (60) | 96 (60) |
Female | 38 (40) | 65 (40) |
Immunophenotype (No.) | ||
Precursor B cell | 65 (68) | 121 (75) |
Precursor T cell | 28 (29) | 38 (24) |
Not specified | 3 | 2 |
WBC, × 109/L (No. [%]) | ||
≤ 30 | 64 (67) | 118 (73) |
30-100 | 18 (19) | 26 (16) |
> 100 | 14 (15) | 17 (11) |
Cytogenetics successful (No. [%]) | 79 (82) | 130 (81) |
Cytogenetic poor-risk features* | ||
t(9;22) | 17 (22) | 21 (16) |
t(4;11) | 4 (5) | 4 (3) |
t(1;19) | 1 (1) | 3 (2) |
Cycles to CR (No. [%]) | ||
1 | 87 (91) | 148 (92) |
2-3 | 9 (9) | 13 (8) |
Prognostic risk category (No. [%])† | ||
Standard | 50 (52) | 88 (55) |
Poor | 46 (48) | 73 (45) |
Time from diagnosis until SCT, mo | ||
Median (range) | 5.2 (2.8-10.8) | 5.4 (3.2-10.2) |
Time from CR1 until SCT, mo | ||
Median (range) | 3.8 (0.5-9.2) | 3.9 (0.4-8.9) |